Research graph
References from Indoxyl Sulfate, Cardiac Biomarkers, and Left Ventricular Wall Thickening in Cats with Chronic Kidney Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Chronic kidney disease in dogs and cats
10.1016/j.cvsm.2012.04.008 · 2012 · External reference
Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies
10.1177/1098612x13511446 · 2014 · External reference
Chronic kidney disease in aged cats: Clinical features, morphology, and proposed pathogeneses
10.1177/0300985815622975 · 2016 · External reference
Feline comorbidities: Cardiovascular and kidney diseases
10.1177/1098612x251407521 · 2026 · External reference
10.3390/toxins12030161
10.3390/toxins12030161 · External reference
ISFM consensus guidelines on the diagnosis and management of hypertension in cats
10.1177/1098612x17693500 · 2017 · External reference
Cardiovascular–renal axis disorders in the domestic dog and cat: A veterinary consensus statement
10.1111/jsap.12387 · 2015 · External reference
Hypertension-driven cardiac remodeling in feline CKD: Diagnostic utility of cTnI/creatinine and NT-proBNP/creatinine ratios
10.33988/auvfd.1691438 · 2025 · External reference
Using cardiac biomarkers in veterinary practice
10.1016/j.cvsm.2013.07.010 · 2013 · External reference
Cardiac biomarkers in cats
10.1016/j.jvc.2015.08.001 · 2015 · External reference
NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults
10.2215/cjn.04910514 · 2015 · External reference
The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease
10.1111/jvim.15389 · 2019 · External reference
Metabolomics reveals alterations in gut-derived uremic toxins and tryptophan metabolism in feline chronic kidney disease
2025 · External reference
Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells
10.1159/000191468 · 2009 · External reference
Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats
10.1016/j.lfs.2013.05.008 · 2013 · External reference
Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway
2015 · External reference
10.3390/toxins12010058
10.3390/toxins12010058 · External reference
Indoxyl sulphate-initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor-erythroid-2-related factor 2
10.1111/jcmm.18192 · 2024 · External reference
Unresolved reference
External reference
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
10.1111/jvim.15331 · 2018 · External reference
Chronic kidney disease in small animals
10.1016/j.cvsm.2010.09.004 · 2011 · External reference
Feline CKD: Pathophysiology and risk factors—What do we know?
10.1177/1098612x13495234 · 2013 · External reference
ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease
10.1177/1098612x16631234 · 2016 · External reference
Interpreting cardiac biomarkers in the setting of chronic kidney disease
10.1373/clinchem.2016.254748 · 2017 · External reference
Plasma N-terminal probrain natriuretic peptide, vascular endothelial growth factor, and cardiac troponin I as novel biomarkers of hypertensive disease and target organ damage in cats
10.1111/jvim.14655 · 2017 · External reference
Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease
10.1016/j.jvc.2009.01.004 · 2009 · External reference
Cardiac troponins and chronic kidney disease
10.1038/sj.ki.5000174 · 2006 · External reference
The comparative diagnostic efficacy of BNP & NT-proBNP in chronic kidney disease patients with complications
10.12669/pjms.41.7.11826 · 2025 · External reference
The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis
10.1016/j.biopha.2024.117050 · 2024 · External reference
Cardiovascular complications in chronic kidney disease: A review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
10.1093/cvr/cvad083 · 2023 · External reference
Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?
10.1093/eurheartj/ehp574 · 2010 · External reference
10.3389/fcvm.2023.990422
10.3389/fcvm.2023.990422 · External reference
The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis
10.1016/j.biopha.2024.117050 · ExternalCitation · doi-reference
Chronic kidney disease in small animals
10.1016/j.cvsm.2010.09.004 · ExternalCitation · doi-reference
Chronic kidney disease in dogs and cats
10.1016/j.cvsm.2012.04.008 · ExternalCitation · doi-reference
Using cardiac biomarkers in veterinary practice
10.1016/j.cvsm.2013.07.010 · ExternalCitation · doi-reference
Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease
10.1016/j.jvc.2009.01.004 · ExternalCitation · doi-reference
Cardiac biomarkers in cats
10.1016/j.jvc.2015.08.001 · ExternalCitation · doi-reference
Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats
10.1016/j.lfs.2013.05.008 · ExternalCitation · doi-reference
Cardiac troponins and chronic kidney disease
10.1038/sj.ki.5000174 · ExternalCitation · doi-reference
Cardiovascular complications in chronic kidney disease: A review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
10.1093/cvr/cvad083 · ExternalCitation · doi-reference
Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?
10.1093/eurheartj/ehp574 · ExternalCitation · doi-reference
Indoxyl sulphate-initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor-erythroid-2-related factor 2
10.1111/jcmm.18192 · ExternalCitation · doi-reference
Cardiovascular–renal axis disorders in the domestic dog and cat: A veterinary consensus statement
10.1111/jsap.12387 · ExternalCitation · doi-reference
Plasma N-terminal probrain natriuretic peptide, vascular endothelial growth factor, and cardiac troponin I as novel biomarkers of hypertensive disease and target organ damage in cats
10.1111/jvim.14655 · ExternalCitation · doi-reference
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
10.1111/jvim.15331 · ExternalCitation · doi-reference
The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease
10.1111/jvim.15389 · ExternalCitation · doi-reference
Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells
10.1159/000191468 · ExternalCitation · doi-reference
Chronic kidney disease in aged cats: Clinical features, morphology, and proposed pathogeneses
10.1177/0300985815622975 · ExternalCitation · doi-reference
Feline CKD: Pathophysiology and risk factors—What do we know?
10.1177/1098612x13495234 · ExternalCitation · doi-reference
Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies
10.1177/1098612x13511446 · ExternalCitation · doi-reference
ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease
10.1177/1098612x16631234 · ExternalCitation · doi-reference
ISFM consensus guidelines on the diagnosis and management of hypertension in cats
10.1177/1098612x17693500 · ExternalCitation · doi-reference
Feline comorbidities: Cardiovascular and kidney diseases
10.1177/1098612x251407521 · ExternalCitation · doi-reference
The comparative diagnostic efficacy of BNP & NT-proBNP in chronic kidney disease patients with complications
10.12669/pjms.41.7.11826 · ExternalCitation · doi-reference
Interpreting cardiac biomarkers in the setting of chronic kidney disease
10.1373/clinchem.2016.254748 · ExternalCitation · doi-reference
NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults
10.2215/cjn.04910514 · ExternalCitation · doi-reference
10.3389/fcvm.2023.990422
10.3389/fcvm.2023.990422 · ExternalCitation · doi-reference
10.3390/toxins12010058
10.3390/toxins12010058 · ExternalCitation · doi-reference
10.3390/toxins12030161
10.3390/toxins12030161 · ExternalCitation · doi-reference
Hypertension-driven cardiac remodeling in feline CKD: Diagnostic utility of cTnI/creatinine and NT-proBNP/creatinine ratios
10.33988/auvfd.1691438 · ExternalCitation · doi-reference
